SEC Comment Letter for PAVmed Inc. (PAVM) (CIK 0001624326) (PAVM) — Jan 9, 2018
PAVmed Inc. (PAVM) (CIK 0001624326)
Date: Jan. 9, 2018 · CIK: 0001624326 · Accession: 0000000000-18-000789
AI Filing Summary & Sentiment
Reasoning
Letter
Mail Stop 3030 January 5, 2018 Via E -mail Lishan Aklog, M.D. Chairman and Chief Executive Officer PAVmed Inc. One Grand Central Place 60 E.42ND Street Suite 4600 New York, New York, 10165
Re: PAVmed Inc. Registration Statement on Form S-1 Filed December 21, 2017 , as amended January 4, 2018 File No. 333 -222234
Dear Dr. Aklog :
This is to advise you that we have not reviewed and will not review your registration statement .
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tom Jones at (202) 551 -3602 with any questions.
Sincerely,
/s/ Tom Jones for
Show Raw Text
Mail Stop 3030
January 5, 2018
Via E -mail
Lishan Aklog, M.D.
Chairman and Chief Executive Officer
PAVmed Inc.
One Grand Central Place
60 E.42ND Street
Suite 4600
New York, New York, 10165
Re: PAVmed Inc.
Registration Statement on Form S-1
Filed December 21, 2017 , as amended January 4, 2018
File No. 333 -222234
Dear Dr. Aklog :
This is to advise you that we have not reviewed and will not review your registration
statement .
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tom Jones at (202) 551 -3602 with any questions.
Sincerely,
/s/ Tom Jones for
Amanda Ravitz
Assistant Director
Office of Electronics and Machinery
cc: Mark J. Wishner , Esq.